Advertisement

Topics

Active Biotech AB Interim report January - June 2015

04:31 EDT 7 Aug 2015 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
· Operations focused on the laquinimod projects and organization adjusted accordingly Laquinimod· The pivotal CONCERTO clinical Phase III study in relapsing remitting MS (RRMS) is fully enrolled and results are expected in 2017· The first pa...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Active Biotech AB Interim report January - June 2015 "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...